The PREPARE Act of 2025 creates a temporary, expert commission to design a prompt and plausible federal regulatory framework for cannabis, modeled generally on alcohol regulation. The commission’s mandate is diagnostic and advisory: it must identify legal, administrative, public-health, and commercial barriers created by federal prohibition and recommend specific measures to address criminalization, research limits, financial exclusion, product safety, and trade issues.
For regulated-industry leaders, state and tribal regulators, and agency compliance officers, the bill matters because it centralizes cross-agency expertise (DOJ, FDA, Treasury, USDA, NHTSA, and others) and requires public engagement with industry participants and people previously convicted for cannabis offenses. The resulting recommendations—published publicly—are intended to guide how Congress and federal agencies could transition from prohibition to a regulated adult-use system while accounting for state and tribal rights and public-health protections.
At a Glance
What It Does
The Attorney General must set up a Commission on the Federal Regulation of Cannabis to study and recommend a pathway to federal cannabis regulation. The Commission solicits public comment, holds public witness hearings with specified participant categories, and issues an initial set of findings and a final report for publication on the Department of Justice website.
Who It Affects
Federal agencies with regulatory or enforcement roles (DOJ, FDA, Treasury, USDA, NHTSA, ATF, IRS, SBA, Commerce, VA, HUD, Labor) and state/tribal cannabis regulators will participate or interact with the Commission. Cannabis businesses, banks, researchers, medical providers, and communities affected by past criminalization are direct stakeholders in the Commission’s work.
Why It Matters
The Commission is the first statutory, cross‑agency vehicle in this bill to coordinate federal thinking about a post‑prohibition regime modeled on alcohol—potentially shaping federal tax, trade, research, public‑health, and licensing policies that will affect interstate commerce and long‑standing barriers to banking and research.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The PREPARE Act establishes an advisory commission housed under the Attorney General to map a realistic federal transition from prohibition to a regulated adult‑use cannabis market. Rather than writing rules, the Commission’s job is to collect evidence, hear affected voices, and produce recommendations that address how federal law can accommodate state and tribal regulatory choices while tackling harms from decades of criminal enforcement.
Membership blends political appointees and agency officials: congressional leaders name experts and certain non‑federal representatives (for example, a member who was formerly incarcerated for a non‑violent cannabis offense), while agency heads or secretaries designate experienced officials from the Departments and federal agencies listed in the statute. That mix is intended to give the Commission technical capacity—on safety, taxation, trade, research, and enforcement—plus lived experience from impacted communities and state regulators.The Commission’s work program focuses on a set list of problem areas: remedies for criminalization (including disproportionate impacts on minority, low-income, and veteran communities); barriers to financial services; obstacles to medical and product‑safety research caused by scheduling; gaps in medical training and patient access; inconsistent product standards and youth protections; revenue collection frameworks; and guidance for crop production, intrastate/interstate trade, and hemp/cannabis coexistence.
It will solicit broad written input, hold public witness hearings that deliberately include certain industry and impacted‑person categories, and publish its recommendations so agencies and Congress can act on them.Operationally the Commission will be supported administratively by the Department of Justice, is expected to meet regularly with quorum and attendance rules, and cannot issue binding regulations or accept compensation for members. Those structural limits mean the Commission’s influence depends on the clarity and political traction of its published findings rather than enforcement power.
The Five Things You Need to Know
The Attorney General must establish the Commission within 30 days of the Act’s enactment.
The Commission must publish initial findings and recommendations and later a final report for public posting on the Department of Justice website.
The Commission’s public witness hearing requirement includes at minimum: a single‑State licensed operator, a multi‑State licensed operator, an individual federally incarcerated for a non‑violent cannabis offense, and an individual incarcerated by a State for a non‑violent cannabis offense.
Membership mixes agency heads and designated experts plus specific political appointees—one of whom must be a person formerly incarcerated for a non‑violent cannabis offense—while the Attorney General supplies staff support if appointing authorities fail to act.
The statute bars the Commission from rulemaking and prohibits members from receiving additional pay or benefits for their service.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the Act the "PREPARE Act of 2025" and frames the legislative vehicle; this is purely formal but signals Congress’s intent that the law produce a preparatory, rather than immediate regulatory, effort.
Congressional findings
The findings catalog historical and contemporary reasons for federal attention—historical prohibition, disparate criminalization impacts, the number of states with medical or adult‑use laws, research obstacles from Schedule I status, and international competitive concerns. These findings narrow the Commission’s focus by calling out research, justice remedies, and industry access as prioritized areas for study.
Purpose and framing
Directs the President and Congress to 'prepare' the federal government for an end to prohibition and instructs the Commission to model a federal framework after alcohol regulation. That framing has practical consequences: it channels the Commission toward licensing, taxation, distribution, and age‑based access models and sets a comparative template that will shape downstream policy options.
Establishment and duties; public engagement
Authorizes the Attorney General to establish the Commission and prescribes a workplan: solicit written comments, convene public witness hearings with required participant types, publish initial recommendations, solicit additional comment, and deliver a final report. Practically, the statute imposes a short, structured public‑input process and creates a public record of testimony and recommendations intended to feed directly into agency and congressional decision‑making.
Membership, governance, and administrative mechanics
Lays out a broad, interagency membership roster (DOJ, FDA, Treasury, Commerce, USDA, NHTSA, ATF, IRS, NIH, VA, SBA, HUD, Labor, NIST, Office of National Drug Control Policy, Office of Minority Health, Indian Health Service, and others), plus specific appointments from congressional leaders and agency secretaries. It includes provisions to cure appointment failures (Attorney General fills vacancies), partisan parity fixes, mandatory meeting cadence and quorum rules, attendance review and potential removal, minutes, and DOJ administrative support. It also forbids compensation and rulemaking authority, meaning the Commission functions as an evidence‑gathering advisory body rather than a regulatory agency.
Definitions
Defines key statutory terms—'cannabis' (tied to the Controlled Substances Act definition of 'marihuana'), 'State' (including territories), 'State cannabis control commission,' and 'Tribal government.' Those definitions will matter when the Commission considers scope questions such as which entities qualify as state regulators and how tribal sovereignty interacts with a federal framework.
This bill is one of many.
Codify tracks hundreds of bills on Government across all five countries.
Explore Government in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and tribal cannabis regulators—They gain a federal clearinghouse of technical guidance and cross‑agency recommendations that could standardize approaches to product safety, interstate commerce, and co‑regulation with federal authorities.
- Patients and the medical community—The Commission explicitly targets expanded medical research access, clinical training gaps, and federal agency engagement, which could lower barriers to clinical trials and federally supported medical guidance.
- Communities affected by criminalization—The statute requires the Commission to propose remedies for disproportionate enforcement impacts and ensures representation for an individual formerly incarcerated for a cannabis offense, giving those communities a formal voice in shaping remedies.
- Cannabis entrepreneurs and financial service providers—Because the Commission must study banking access and recommend frameworks for federal revenue and financial services, the resulting proposals could enable clearer pathways for banking, taxation, and interstate business models.
- Federal agencies and Congress—Agencies receive a consolidated set of technical recommendations to inform policymaking; Congress receives an evidence‑based roadmap that could simplify drafting of successor legislation.
Who Bears the Cost
- Federal agencies named to the Commission—They must allocate senior staff time and subject‑matter experts to participate and produce inputs, and DOJ must provide administrative support, creating resource demands without specific appropriations in the text.
- State‑licensed operators and multistate cannabis businesses—If the Commission’s recommendations call for federal registration, taxation, labeling, or testing standards, businesses will face new compliance costs to align with a federal regime.
- Small businesses from disadvantaged communities—Although the Commission includes a member from SBA focused on access, proposed federal compliance regimes and federal taxation could disproportionately burden smaller operators if transitional support is limited.
- Research institutions and hospitals—Transitioning research access and reconciling federal scheduling with clinical studies will require administrative changes and funding commitments, potentially shifting costs to institutions unless federal research funds are allocated.
- Taxpayers—While Commission members are unpaid, providing DOJ staff support and convening federal participants will incur administrative costs borne by appropriations or reallocated agency budgets.
Key Issues
The Core Tension
The central dilemma is whether to pursue a rapid, uniform federal regulatory model that brings legal clarity and interstate commerce but risks overriding state and tribal policy choices and insufficiently addressing justice and public‑health harms, or to favor a slower, more decentralized approach that preserves local control but prolongs federal legal uncertainty, research barriers, and unequal market access.
The bill creates a highly centralized advisory process but stops short of granting any regulatory power. That structure raises two implementation risks: first, the Commission can only recommend; whether its road map shifts policy depends entirely on follow‑on congressional or agency action.
Second, housing the Commission under DOJ—an agency historically associated with enforcement—may complicate trust with communities seeking restorative justice and with researchers who have experienced federal barriers.
Substantively, modeling a federal system on alcohol regulation is a blunt tool. Alcohol frameworks emphasize age‑restricted retail, excise taxation, and distribution monopolies in some states; cannabis poses additional challenges—diverse product types (edibles, concentrates, inhalants), potency measures, impairment testing, workplace safety, and hemp‑cannabis genetic cross‑contamination—that alcohol law does not address.
The Act also asks the Commission to reconcile competing priorities: protecting youth and public health, enabling medical research and veteran access, restoring justice to impacted communities, and creating a workable interstate trade regime. These goals often pull policy in different directions and require tradeoffs the Commission can only illuminate, not resolve.
Finally, the compressed schedule and detailed hearing requirements create a lot of public input in a short window. That can produce focused, actionable recommendations, but it also risks privileging well‑resourced stakeholders who can respond quickly.
The statute remedies some representation gaps by requiring specific participant types, yet questions remain about how the Commission will weight technical agency expertise against lived‑experience testimony, and how it will quantify tradeoffs (for example, what tax rate balances public revenue against sustaining a legal market that undercuts illicit sellers).
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.